Evidence map›Paper›PMID 35867130›Full record

ArticleDiabetologia2022

Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage.

Amir-Babak Sioofy-Khojine, Sarah J Richardson, Jonathan M Locke, Sami Oikarinen, Noora Nurminen, Antti-Pekka Laine, Kate Downes, Johanna Lempainen, John A Todd, Riitta Veijola and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Amir-Babak Sioofy-KhojineDepartment of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0001-5538-5153
Sarah J RichardsonExeter Centre of Excellence for Diabetes Research (EXCEED), Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.ORCID 0000-0002-1160-6062
Jonathan M LockeExeter Centre of Excellence for Diabetes Research (EXCEED), Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.ORCID 0000-0001-9516-5251
Sami OikarinenDepartment of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0003-3901-6774
Noora NurminenDepartment of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0002-6798-7677
Antti-Pekka LaineImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.ORCID 0000-0003-4962-2882
Kate DownesJDRF/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Johanna LempainenImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.ORCID 0000-0001-9893-1468
John A ToddJDRF/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.ORCID 0000-0003-2740-8148
Riitta VeijolaDepartment for Children and Adolescents, Oulu University Hospital, Oulu, Finland.ORCID 0000-0002-6557-270X
Jorma IlonenImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.ORCID 0000-0002-9973-2062
Mikael KnipPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0003-0474-0033
Noel G MorganExeter Centre of Excellence for Diabetes Research (EXCEED), Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.ORCID 0000-0003-1537-8113
Heikki HyötyDepartment of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0003-0370-4145
Mark PeakmanDepartment of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK.ORCID 0000-0003-3328-3513
Martin EichmannExeter Centre of Excellence for Diabetes Research (EXCEED), Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK. m.eichmann@exeter.ac.uk.ORCID 0000-0002-8675-2822
Tampere University · FIUniversity of Exeter · GBUniversity of Turku · FIKing's College London · GBCentre for Human Genetics · GBOulu University Hospital · FIUniversity of Cambridge · GBUniversity of Helsinki · FI

Funding

Medical Research Council MR/P010695/1Wellcome Trust 07212/A/15/Z
6 · The paper itself

Abstract

aims/hypothesisEnteroviral infection has been implicated consistently as a key environmental factor correlating with the appearance of autoimmunity and/or the presence of overt type 1 diabetes, in which pancreatic insulin-producing beta cells are destroyed by an autoimmune response. Genetic predisposition through variation in the type 1 diabetes risk gene IFIH1 (interferon induced with helicase C domain 1), which encodes the viral pattern-recognition receptor melanoma differentiation-associated protein 5 (MDA5), supports a potential link between enterovirus infection and type 1 diabetes.

methodsWe used molecular techniques to detect enterovirus RNA in peripheral blood samples (in separated cellular compartments or plasma) from two cohorts comprising 79 children or 72 adults that include individuals with and without type 1 diabetes who had multiple autoantibodies. We also used immunohistochemistry to detect the enteroviral protein VP1 in the pancreatic islets of post-mortem donors (n=43) with type 1 diabetes.

resultsWe observed enhanced detection sensitivity when sampling the cellular compartment compared with the non-cellular compartment of peripheral blood (OR 21.69; 95% CI 3.64, 229.20; p<0.0001). In addition, we show that children with autoimmunity are more likely to test positive for enterovirus RNA than those without autoimmunity (OR 11.60; 95% CI 1.89, 126.90; p=0.0065). Furthermore, we found that individuals carrying the predisposing allele (946 CONCLUSIONS/

interpretationOur data indicate that, in peripheral blood, antigen-presenting cells are the predominant source of enterovirus infection, and that infection is correlated with disease stage and genetic predisposition, thereby supporting a role for enterovirus infection prior to disease onset.

Indexed as

Diabetes Mellitus, Type 1EnterovirusEnterovirus InfectionsInsulinsAdultAllelesAutoantibodiesChildDEAD-box RNA HelicasesGenetic Predisposition to DiseaseHumansInterferon-Induced Helicase, IFIH1Leukocytes, MononuclearRNAAutoantibodiesDEAD-box RNA HelicasesIFIH1 protein, humanInsulinsInterferon-Induced Helicase, IFIH1RNAAutoimmunityEnterovirusGenetic riskIFIH-1Interferon induced with helicase C domain 1MDA5Melanoma differentiation-associated protein 5Pancreatic isletsrs1990760Type 1 diabetes

Identifiers

PMID35867130
PMCPMC9477938
OpenAlexW4286560639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.